Product finder
Adipose Tissue Progenitor Isolation Kit, mouse
Getting pure progenitor cells from brown or white adipose tissue has never been easier!
March 23, 2015
Anti-SCA-1 (non-HSC) MicroBeads, mouse
Isolate SCA-1-+ cells directly from non-hematopoietic tissues.
March 23, 2015
Cardiac Endothelial Cell Isolation Kit, rat
Quickly isolate cardiac endothelial cells from neonatal hearts.
March 23, 2015

MACSxpress CD4 Memory T Cell Isolation Kit

Fast isolation of untouched CD4+ memory T cells from freshly drawn anti-coagulated whole blood without ficoll - the MACSxpress CD4 Memory T Cell Isolation Kit.

March 6, 2015
Precisely targeted regulation
Stefan Miltenyi speaks to lab&more magazine about the potential of lentiviral technology
February 23, 2015
Miltenyi Biotec acquires gene therapy assets from Lentigen corporation
Miltenyi Biotec announced today that it has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen Corporation, a global leader in lentiviral technology for cell and gene therapy applications.
August 14, 2014
CiteAb highlights Miltenyi Biotec
The world's most popular antibody search engine CiteAb is featuring Miltenyi Biotec on its start page highlighting company facts and our brand new REAfinity™ Antibodies. This prominent placement helps to position Miltenyi Biotec as a high-quality flow antibody provider. A valuable characteristic of this search engine is that the results are ranked by citations, which is a significant quality criterion to trigger antibody purchases.
June 23, 2014
DDG - 48. Tagung der Deutschen Dermatologischen Gesellschaft
Berlin, Germany - April 29 - May 2
AAI Annual Meeting - IMMUNOLOGY 2015™
New Orleans LA, USA - May 8-12
Symposium at ISCT
Las Vegas NE, USA - May 27; 4:30pm - 6:30pm
21st ISCT Annual Meeting
Las Vegas NE, USA - May 27-30

Customer login


Forgot password?
Register for account

0 Shopping cart


Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
Contact overview

Product finder

Antibody panel builder


Change country

Please select your country to continue